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An 81-year old non-smoker and retired nurse pre-
sented with a painful swelling to the left index
finger. The pain had been present for several months
beforehand. There was a history of a small burn
prior to presentation. She had no constitutional
symptoms and was otherwise in very good health.
A radiograph of the hand demonstrated the soft
tissue swelling alone with no bone involvement.
Initially it was thought to be an abscess hence she
was commenced on antibiotics and an incision and
drainage procedure was carried out. Tough chronic
inflammatory tissue was found adherent to the
flexor tendon sheath. Specimens were sent to
microbiology and histology. This had no growth
and demonstrated a chronic granulomatous lesion
with no evidence of any specific organism. The
lesion had a neutrophil infiltrate centre surrounded
by a predominantly hystiocytic infiltrate. She con-
tinued on antibiotics for 4 weeks. At this point
motion in her finger was considered good–—she
was able to make a fist, and appearances suggested
the infection had almost cleared.* Corresponding author. Tel.: +44 1604 885 004;
fax: +44 1604 885 004.
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then redeveloped significant soft tissue swelling
and inflammation. At this point she was referred
to a rheumatologist who performed routine blood
tests and aspirated some fluid from the finger. Her
WCC was 5.8  109/l (4—11), ESR 38 mm/hr (1—10)
and ANAwas negative. However her CRP was slightly
elevated at 13 mg/l (0—6) as was her serum ACE at
84 U/l (8—52) and her Rheumatoid Factor was nega-
tive. The aspirate proved negative for growth and
AFB even after 6 weeks incubation. She also tested
negatively with Mantoux testing. It was noted she
was an avid bird feeder but did not keep birds and
had not been pecked, nor did she have a swimming
pool. No other joints were affected and her hand
and chest radiographs were clear. It was therefore
assumed at this stage that this was sarcoid or a form
of chronic post-operative inflammatory process and
she was commenced on steroid therapy.
Four months later, due to the size of the swelling
on the palmar aspect of the proximal phalanx (see
Fig. 1 & 2), she was referred back to orthopaedics
for re-exploration. On this occasion further cultures
for tuberculosis were taken. Two months later a
report came through that it was an ‘anonymous’
mycobacterium and she was commenced on rifater
(rifampicin, isoniazid and pyrazinamide),) etham-
butol and pyridoxine (Vitamin B6). Finally 2 months
after that it was reported asMycobacterium terrae,
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Figure 1 Lateral photograph of left index finger dacti-
litis.
Figure 2 Volar aspect of finger. Initial drainage proce-
dure scar can be seen.an atypical mycobacterium that has been associated
with penetrating injuries to the fingers. She was
therefore continued on rifampicin and ethambutol
for a further 4 months. By the end of the 6 months
course she was fully recovered and discharged.Discussion
The German physician Heinrich Koch (1843—1910)
was the first scientist to identify and grow the
tubercle bacillus in 1882 amongst other equally
devastating pathogens such as cholera.
Itwas to be some50 years before Pinner coined the
term ‘atypical acid-fast microorganisms’ in that he
could differentiate other mycobacteria from tuber-
culosis and over the ensuing decades more and more
mycobacteria were reported as advances in technol-
ogies emerged for the analysis of phenotypes. Other
terms used have included ‘mycobacteria other than
tubercle’ bacilli, or MOTT, and ‘non-tuberculous’
mycobacteria. These terms all set tuberculosis as
the standard and hence lately have run into some
disagreement as to their use. The major differentia-tion between these species in practical terms is their
pathogenicity, normal habitats and relative conta-
giousness. Tuberculosis is contagious, is not found
free in theenvironment, and is transmittedonly by an
infected mammalian host. Most other mycobacteria
have demonstrated very little human-to human
transmission and are found in the environment.9
M. terrae is an uncommon organism having been
mentioned in the worldwide literature only seven
times with regards to infection in the hand since the
late 1970s. It is otherwise known as the radish
bacillus having been first identified from the leaves
of radish plants. It is a member of the M. terrae
complex, which also includesM. nonchromogenicum
and M. triviale. Clinical disease is rarely associated
with this group which is slow growing, saprophytic
and rarely pathogenic.
It has been suggested that the emergence of these
atypical or opportunistic micro-organisms is in rela-
tion to a fall in immunocompetence as an outcome to
the HIV virus however in the prior reported cases the
patient was healthy except one case where the
patient had diabetes and arterial insufficiency.3
There appears to be conflicting reports thus far
on the treatment of M. terrae. Options include
combinations of surgical and pharmaceutical
agents. This is mainly due to scarcity of reports of
this type of pathogen and the increased confounding
morbidity associated with non-implemented appro-
priate treatment due to its usual delayed diagnosis.
In two previous cases steroids were given before the
diagnosis was made. What is known is that suscept-
ibility testing might be useful if the laboratory can
do it. In the reported cases outcome has been
variable. In two cases surgical debridement was
all that was necessary.2,5 In two further cases ampu-
tation became necessary after surgery and che-
motherapy failed.3,8 Our case is in agreement
with three others1,4,6 in that a combination of deb-
ridement and chemotherapy proved to be the cure.Conclusion
This case highlights the need to include ‘atypical’
bacteria in the differential diagnosis of chronic
swellings. It goes on to highlight the how false
positives can give a false sense of security and lead
to a very wrong treatment rationale. If treatment is
not giving the expected result it is worth re-explor-
ing the diagnosis/investigation possibilities.
The authors advocate the use of a combination of
surgery (for specimen retrieval, symptom relief/
debulking and potential cure) and chemotherapy as
the best line in treatment of atypical mycobacterial
infections, concurring with the emerging trend.
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